Microbot Medical Inc. — Director's Dealing 2021

Apr 7, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Microbot Medical Inc. (MBOT)
CIK: 0000883975
Period of Report: 2021-04-07

Reporting Person: Sharon Simon (General Manager & CTO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$9.00	2028-08-13	Common Stock, par value $0.01 per share (10000)		Direct
Stock Option (Right to Buy)	$5.95	2029-08-12	Common Stock, par value $0.01 per share (14170)		Direct

Footnotes

F1: The option vests as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on February 13, 2019, the option vested and became exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.

F2: The option vests as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on February 12, 2020, the option vested and became exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.